AMAleksandra V. Moiseeva

Aleksandra V. Moiseeva

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Aleksandra V. Moiseeva has a total of 42 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Новая модель прогнозирования риска для оценки повреждения миокарда у пожилых пациентов после экстренного оперативного вмешательства: роль полифармакотерапии

    by Denis N. Shimanovskiy, Шимановский Денис Николаевич, Alexandr B. Zudin, Зудин Александр Борисович, Marina M. Shegai, Шегай Марина Михайловна, Alexandra V. Moiseeva, Моисеева Александра Викторовна

    Many studies conducted in the field of cardiology have recently shown that elderly patients (≥ 65 years old) who undergo emergency non-cardiac surgery have a significantly higher mortality rate (12.5%) compared to patients who undergo elective surgery (2.6%). In this regard, many doctors are wondering whether it is possible to reliably predict myocardial injury after non-cardiac surgery (MINS) at the preoperative stage. The search was conducted in January–September 2025 using the PubMed, Scopus, and Web of Science databases. Publications from 2005 to 2025 were considered. The review included original articles, meta-analyses, and systematic analyses relevant to the selected topic.

  • Open Access

    Comparative Transcriptomics Study of Curcumin and Conventional Therapies in Translocation, Clear Cell, and Papillary Renal Cell Carcinoma Subtypes

    by Moses Owoicho Abah, Deborah Oganya Ogenyi, Angelina V. Zhilenkova, Freddy Elad Essogmo, Ikenna Kingsley Uchendu, Yvan Sinclair Ngaha Tchawe, Akaye Madu Pascal, Natalia M. Nikitina, Onoja Solomon Oloche, Maria Pavliv, et al.

    Currently, there is no standard treatment for renal cell carcinoma (RCC) that is free of side effects and resistance. Additionally, limited information exists on how curcumin affects the gene expression profiles of patients with translocation renal cell carcinoma (tRCC) and papillary renal cell carcinoma (pRCC). The pathways responsible for metastasis in tRCC are still not well understood, and there is no established treatment or reliable biomarker to predict outcomes for metastatic tRCC. Primary clinical data from patients were retrieved from the TCGA database and analyzed using cBioPortal, stitch, string, R and Python. Various analyses were performed, including differential gene expression, protein-protein interaction (PPI) network analysis, drug-targeted gene analysis, gene ontology (GO), enrichment analyses, and systematic searches to assess the impact of curcumin on the transcriptomic profiles of tRCC, pRCC, and clear cell renal cell carcinoma (ccRCC). No significant impact of sensitive genes on survival in KIRC and KIRP was found, though a trend suggested they may delay disease progression. The combination of curcumin with sunitinib showed promise in overcoming drug resistance in ccRCC by inducing ferroptosis, reducing iron, and increasing ADAMTS18 expression. This study, leveraging data from the TCGA database and other databases explored the impact of curcumin on transcriptomic profiles in tRCC, pRCC, and clear cell RCC (ccRCC). Gene analysis revealed immune and metabolic differences, with KIRC showing a stronger immune response. This study is the first to propose that future research into the miR-148/ADAMTS18 genes and the ferroptosis pathway in tRCC and pRCC could lead to the development of new therapies and the identification of novel therapeutic targets, potentially overcoming drug resistance and metastasis.


  • Open Access

    Innovative Therapies Targeting Drug-Resistant Biomarkers in Metastatic Clear Cell Renal Cell Carcinoma (ccRCC)

    by Moses Owoicho Abah, Deborah Oganya Ogenyi, Angelina V. Zhilenkova, Freddy Elad Essogmo, Yvan Sinclair Ngaha Tchawe, Ikenna Kingsley Uchendu, Akaye Madu Pascal, Natalia M. Nikitina, Alexander S. Rusanov, Varvara D. Sanikovich, et al.

    A thorough study of Clear Cell Renal Cell Carcinoma (ccRCC) shows that combining tyrosine kinase inhibitors (TKI) with immune checkpoint inhibitors (ICI) shows promising results in addressing the tumor-promoting influences of abnormal immunological and molecular biomarkers in metastatic Clear Cell Renal Cell Carcinoma (ccRCC). These abnormal biomarkers enhance drug resistance, support tumor growth, and trigger cancer-related genes. Ongoing clinical trials are testing new treatment options that appear more effective than earlier ones. However, more research is needed to confirm their long-term safety use and potential side effects. This study highlights vital molecular and immunological biomarkers associated with drug resistance in Clear Cell Renal Cell Carcinoma (ccRCC). Furthermore, this study identifies a number of promising drug candidates and biomarkers that serve as significant contributors to the enhancement of the overall survival of ccRCC patients. Consequently, this article offers pertinent insights on both recently completed and ongoing clinical trials, recommending further toxicity study for the prolonged use of this treatment strategy for patients with metastatic ccRCC, while equipping researchers with invaluable information for the progression of current treatment strategies.


  • Open Access

    MOLECULAR AND MORPHOLOGICAL MARKERS OF NEURONAL DEATHIN ACUTE CEREBRAL CIRCULATIONDISORDERS

    by V.A. Kudryavtseva, E.A. Kuzmin, A.V. Moiseeva, M.S. Obelchakova, P.A. Sinitsyna, G.A. Piavchenko, N.L. Kartashkina, A.G. Alekseev, A.M. Golubev, M.A. Zatolokina, et al.

    Resume. Acute cerebral circulatory disorders are characterised by various changes in brain cells, often leading to mass death. This review presents a list of markers associated with different types of cell death occurring in acute cerebral circulation disorders and identifies the importance of these markers in the diagnosis of haemorrhagic and ischaemic stroke. Acute cerebral circulation disorder is one of the most debated issues in modern resuscitation and medicine, as it is a severe condition leading to stroke and subsequent patient death, if not treated promptly. However, rapid treatment and diagnosis of stroke is difficult due to the lack of study of morphological signs and biomarkers to reliably determine the nature of the injury. An in-depth analysis and systematization of the available information on this topic is needed. Purpose of the review: to reveal the correspondence between the molecular mechanisms of cell death in acute disorders of cerebral circulation and their morphological manifestations. Material and Methods. A total of 50 most relevant sources of information were selected. The sources were selected from the databases of medical and biological publications PubMed, Scopus, Web of Science, RSCI, and fundamental works of scientific literature on the considered topic were involved. Results. The main mechanisms of cell death in stroke were identified and analyzed, the morphological and histological features of the observed processes and their structural manifestations were reviewed. Besides, the most frequently detected molecular markers specific for each type of cell death were listed. Conclusion. The study of molecular pathways and cellular reorganization processes characteristic of different types of cell death as well as their corresponding biological markers is of important diagnostic value in the detection of cerebral circulatory disorders. Determination of morphological and molecular markers typical for this condition will allow a prompt diagnosis of stroke and minimization of its negative consequences.

  • Open Access

    Genetic determination of the ovarian reserve: a literature review

    by Aleksandra V. Moiseeva, Varvara A. Kudryavtseva, Vladimir N. Nikolenko, Marine M. Gevorgyan, Ara L. Unanyan, Anastassia A. Bakhmet, Mikhail Y. Sinelnikov

    The ovarian reserve is one of the most important indicators of female fertility. It allows for the evaluation of the number of viable oocytes. This parameter is actively used in pregnancy planning and in assisted reproductive technology application, as it determines chances of successful fertilization and healthy pregnancy. Due to increased attention towards diagnostic tests evaluating the ovarian reserve, there has been a growing interest in factors that influence the state of the ovarian reserve. True reasons for pathological changes in the ovarian reserve and volume have not yet been explored in depth, and current diagnostic screening methods often fall short in efficacy. In the following review we analyze existing data relating to the study of the ovarian reserve through genetic testing, determining specific characteristics of the ovarian reserve through genetic profiling. We explore existing studies dedicated to finding specific genetic targets influencing the state of the ovarian reserve.